Therapeutic Action
Sedating H1 antihistamine
Source page 265
Individual generic drug information
Extracted information for PROMETHAZINE only.
Sedating H1 antihistamine
Source page 265
Insomnia Agitation or aggressive behaviour in patients with acute or chronic psychosis, in combination with haloperidol
Source page 265
Extracted information for PROMETHAZINE only.
Administer with caution and monitor use: in older patients; in patients with prostate disorders, closed-angle glaucoma, epilepsy, orthostatic hypotension, severe renal or hepatic impairment; in patients taking central nervous system depressants (opioid analgesics, antipsychotics, sedatives, antidepressants, etc.) or drugs known to have an anticholinergic effect (atropine, amitriptyline, chlorpromazine, etc.). May cause: drowsiness (caution when driving/operating machinery), dizziness, headache, confusional state, hypotension, photosensitivity (protect skin from sun exposure); anticholinergic effects (dry mouth, constipation, blurred vision, tachycardia, disorders of micturition); rarely: seizures, extrapyramidal symptoms, neuroleptic malignant syndrome (unexplained hyperthermia with neuromuscular disorders), allergic reactions. Avoid alcohol during treatment (increased risk of adverse effects). Pregnancy and breast-feeding: avoid
Source pages 265, 266
Extracted information for PROMETHAZINE only.
25 mg tablet
Source page 265
Insomnia Adult: 25 mg once daily at bedtime for 7 to 10 days max. Agitation or aggressive behaviour in patients with acute or chronic psychosis, with haloperidol Adult: 25 mg, to be repeated after 60 minutes if necessary
Source page 265
Extracted information for PROMETHAZINE only.
Promethazine is not included in the WHO list of essential medicines.
Source page 266
– – Below 25 °C
Source page 266
Filter the extracted dose blocks for this individual drug.
25 mg once daily at bedtime for 7 to 10 days max.
Candidate age grouping · source page 265
25 mg, to be repeated after 60 minutes if necessary
Candidate age grouping · source page 265